| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/06/2002 | WO2001083752A3 23949 and 32391, human ion channels and uses thereof |
| 09/06/2002 | WO2001079515A3 Methods of identifying transgenic plants using morphological markers |
| 09/06/2002 | WO2001079276A3 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| 09/06/2002 | WO2001079270A3 Migraine and vasodilation treatment |
| 09/06/2002 | WO2001075068A9 Secreted proteins and polynucleotides encoding them |
| 09/06/2002 | WO2001072822B1 Genes involved in intestinal inflammatory diseases and use thereof |
| 09/06/2002 | WO2001070773A3 Insecticidal peptides and methods for using same |
| 09/06/2002 | WO2001064738A3 Heparin-binding amino acid sequences derived from human proteins facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/06/2002 | WO2001058915A8 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 09/06/2002 | WO2001049834A3 Preparation of deallergenized patatin proteins and patatin permutein proteins |
| 09/06/2002 | WO2001046253A9 A new polypeptide-calcitonin 11 and the polynucleotide encoding it |
| 09/06/2002 | WO2001032614A9 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 09/06/2002 | WO2001031021A9 Multiple sclerosis-related superantigen |
| 09/06/2002 | WO2001030851A9 Idiotype vaccines |
| 09/06/2002 | WO2001027291A9 Design of a polyepitopic construct for the induction of hla-a2.1 restricted hiv 1 specific ctl responses using hhd mice |
| 09/06/2002 | WO2001024681A9 Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same |
| 09/06/2002 | WO2001018546A9 Screening for inhibitors of 'paired helical filaments' |
| 09/06/2002 | WO2001018199A9 Chimaeric plant viruses with mucin peptides |
| 09/06/2002 | WO2001018035A9 Muc-1 derived peptides |
| 09/06/2002 | WO2001016177A9 Mouse g-protein coupled 7 transmembrane receptor, canoman |
| 09/06/2002 | WO2001013937A9 Peptides capable of modulating the function of cd66 (ceacam) family members |
| 09/06/2002 | WO2001012674A9 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 09/06/2002 | WO2001007059A9 Matrix-targeted fusion polypeptides for tissue regeneration and wound healing |
| 09/06/2002 | WO2001005945A9 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 09/06/2002 | WO2001004334A9 Infection with chimaeric adenoviruses of cells negative for the adenovirus serotype 5 coxsacki adenovirus receptor (car) |
| 09/06/2002 | WO2000078955A9 Epithelial cell growth inhibitors |
| 09/06/2002 | WO2000073462A9 Attenuated mutant enteropathogenic e. coli (epec) strains, process for their production and their use |
| 09/06/2002 | WO2000067761A9 Compositions and methods for identifying antigens which elicit an immune response |
| 09/06/2002 | WO2000065062A9 Genome sequence and polypeptides of pyrococcus abissy, fragment and uses thereof |
| 09/06/2002 | CA2756609A1 Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
| 09/06/2002 | CA2674673A1 Modified and stabilized gdf propeptides and uses thereof |
| 09/06/2002 | CA2477043A1 Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer |
| 09/06/2002 | CA2444493A1 Method for identifying biologically active structures of microbial pathogens |
| 09/06/2002 | CA2440740A1 Hla ligand database utilizing predictive algorithms and methods of making and using same |
| 09/06/2002 | CA2439529A1 Proteins and nucleic acids encoding same |
| 09/06/2002 | CA2439492A1 Tri-hybrid melanoma antigen |
| 09/06/2002 | CA2439472A1 Methods and compositions for modifying apolipoprotein b mrna editing |
| 09/06/2002 | CA2439400A1 Non-oligomerizing tandem fluorescent proteins |
| 09/06/2002 | CA2439383A1 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 09/06/2002 | CA2439335A1 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas |
| 09/06/2002 | CA2439303A1 Methods for identifying peptides which modulate a biological process |
| 09/06/2002 | CA2439294A1 Cea-expression inhibiting ribozymes and methods for the treatment of cancer based thereon |
| 09/06/2002 | CA2439190A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 09/06/2002 | CA2439185A1 Vector constructs |
| 09/06/2002 | CA2439175A1 Opiate receptors |
| 09/06/2002 | CA2439168A1 Modified thrombopoietin with reduced immunogenicity |
| 09/06/2002 | CA2439155A1 Isolated human tumor supressor proteins, nucleic acid molecules encoding these human tumor supressor proteins, and uses thereof |
| 09/06/2002 | CA2438943A1 Hin-1, a tumor suppressor gene |
| 09/06/2002 | CA2438923A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/06/2002 | CA2438886A1 Fusion protein for the secretion of a protein of interest into the supernatant of the bacterial culture |
| 09/06/2002 | CA2438652A1 Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity |
| 09/06/2002 | CA2438238A1 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
| 09/06/2002 | CA2438212A1 Biosensor for detecting chemical agents |
| 09/06/2002 | CA2438204A1 Ascorbic acid analogs for metalloradiopharmaceuticals |
| 09/06/2002 | CA2437898A1 Interferon-alpha induced gene |
| 09/06/2002 | CA2437516A1 Heterocarpine, a human ghrh-binding protein |
| 09/06/2002 | CA2437364A1 Proteins and nucleic acids encoding same |
| 09/06/2002 | CA2437313A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/06/2002 | CA2437218A1 Modified and stabilized gdf propeptides and uses thereof |
| 09/06/2002 | CA2434690A1 Proteins, polynucleotides encoding them and methods of using the same |
| 09/06/2002 | CA2433474A1 70 human secreted proteins |
| 09/06/2002 | CA2433469A1 83 human secreted proteins |
| 09/06/2002 | CA2430702A1 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 09/06/2002 | CA2362784A1 Methods for producing protein domains and analyzing three dimensional structures of proteins by using said domains |
| 09/05/2002 | US20020124286 Plants resistant to WT strains of cucumber mosaic virus |
| 09/05/2002 | US20020124284 Nucleotide sequences coding root regulatory polypeptide for use in soil remediation and prevention of soil erosion |
| 09/05/2002 | US20020124282 Plant reproduction polynucleotides and methods of use |
| 09/05/2002 | US20020124279 Mre11 orthologue and uses thereof |
| 09/05/2002 | US20020124274 Delivery system |
| 09/05/2002 | US20020124273 Protein-protein interactions in neurodegenerative diseases |
| 09/05/2002 | US20020123623 Nucleotide sequences coding transcription factor for use in the generation of disease resistant and pest resistant plants |
| 09/05/2002 | US20020123619 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer |
| 09/05/2002 | US20020123618 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of autoimmune, thyroid and grave's disease |
| 09/05/2002 | US20020123617 Novel immunoglobulin superfamily members of APEX-1, APEX-2 and APEX-3 and uses thereof |
| 09/05/2002 | US20020123614 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 09/05/2002 | US20020123613 Protein for use in the treatment and diagnosis of cell differentiation and cell maintainance defects |
| 09/05/2002 | US20020123612 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 09/05/2002 | US20020123611 Membrane polypeptides for use in treatment of kidney defects |
| 09/05/2002 | US20020123517 Method for controlling cell necrosis or apoptosis |
| 09/05/2002 | US20020123481 C-fos induced growth factor (FIGF) and DNA encoding same |
| 09/05/2002 | US20020123477 Contacting a target cell with DNA-damaging agent; removing DNA-damaging agent from target cell; transferring transgene into target cell between about 1-3 days after removing DNA-damaging agent |
| 09/05/2002 | US20020123474 Human GTP-Rho binding protein2 |
| 09/05/2002 | US20020123473 For therapy of asthma |
| 09/05/2002 | US20020123465 Administering transforming growth factor alpha (TGF- alpha ) polypeptide, fragments and mimetics to tissue or organ prior to, simultaneously with or subsequent to contacting the tissue or organ with the cytotoxic agent |
| 09/05/2002 | US20020123464 Used for assessing whether test compound is useful for modulating phenomenon selected from group consisting of cell signaling, cell growth, cell differentiation, tumorigenesis, tumor growth, tumor metastasis, cell motility, etc. |
| 09/05/2002 | US20020123463 As diagnostics, biosensors and bioreactors, pharmaceuticals |
| 09/05/2002 | US20020123462 Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 09/05/2002 | US20020123458 Endostatin protein and fragments thereof |
| 09/05/2002 | US20020123457 Novel antiplatelet agent |
| 09/05/2002 | US20020123454 Assaying ability of compound to modulate a NT69 nucleic acid expression or NT69 polypeptide activity, thereby identifying a compound capable of treating a pain disorder |
| 09/05/2002 | US20020123147 Gene transfer with adenoviruses having modified fiber proteins |
| 09/05/2002 | US20020123139 Antibodies which bind specifically to activin receptor like kinases |
| 09/05/2002 | US20020123138 Human VNO receptor (R1) |
| 09/05/2002 | US20020123119 Nucleotide sequences coding enzymatic polypeptide for use in screening bactericides and for treatment and prevention of infections |
| 09/05/2002 | US20020123117 Modulator for use in the diagnosis and treatment of rheumatic diseases, cachexia and eating disorders |
| 09/05/2002 | US20020123116 Suppressor protein for use in diagnosis, detection and treatment of cell proliferation and apoptosis defects |
| 09/05/2002 | US20020123115 Nucleotide sequences coding enzymatic polypeptide for use in detection and treatment of cancer |
| 09/05/2002 | US20020123114 Polypeptide for use in the diagnosis of cancer of the nervous system |
| 09/05/2002 | US20020123113 Genetically adjusted fluorescent protein for use as detection tool genetic engineering |
| 09/05/2002 | US20020123108 Fusion proteins between antigenic amino acid sequences and beta-2- microglobulin |